N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-D-alaninamide trifluoroacetate salt; 17: PN: WO2007012430 SEQID: 19 claimed protein trifluoroacetate salt; 1: PN: WO02056903 PAGE: 25 claimed protein trifluoroacetate salt; 5: PN: WO0018423 PAGE: 26 claimed protein trifluoroacetate salt; Abarelix trifluoroacetate salt; PPI 149 trifluoroacetate salt; Plenaxis trifluoroacetate salt; R 3827 trifluoroacetate salt; Abarelix TFA
備用CAS:
183552-38-7
分子式:
C??H??ClN??O?? • x(C ?HF?O?)
狀態(tài)：
白色至白色固體
分子量:
1416.06114
儲存：
Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解性:
Methanol (Slightly), Water (Slightly)
類別:
Standards; Amino Acids; Amino Acids/Peptides; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Abarelix TFA salt is a drug to treat patients with androgen-independent prostate cancer which results in reduction of circulating FSH (follicle-stimulating hormone).
?您的位置：
